GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

$61.41 -0.63 (-1.02%)

Closing price 04:00 PM Eastern

Extended Trading

$61.54 +0.14 (+0.22%)

As of 07:51 PM Eastern

Compare

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 21 Analyst Ratings

Sell
0

Hold
11

Buy
10

Based on 21 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Hold." Out of the 21 analysts, 11 have given a hold rating, and 10 have given a buy rating for GEHC.

Consensus Price Target

$76.41
24.42% Upside

According to the 21 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $76.41. The highest price target for GEHC is $98.00, while the lowest price target for GEHC is $14.00. The average price target represents a forecasted upside of 24.42% from the current price of $61.41.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

Type	Current Forecast 7/22/25 to 7/22/26	1 Month Ago 6/22/25 to 6/22/26	3 Months Ago 4/23/25 to 4/23/26	1 Year Ago 7/22/24 to 7/22/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	10 Buy rating(s)	9 Buy rating(s)	8 Buy rating(s)	8 Buy rating(s)
Hold	11 Hold rating(s)	9 Hold rating(s)	6 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$76.41	$80.21	$88.77	$88.55
Forecasted Upside	24.42% Upside	32.27% Upside	27.01% Upside	15.76% Upside
Consensus Rating	Hold	Moderate Buy	Hold	Moderate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GE HealthCare Technologies Stock vs. The Competition

Type	GE HealthCare Technologies	Medical Companies	Broader Market
Consensus Rating Score	2.48	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	23.80% Upside	888.95% Upside	14.41% Upside
News Sentiment Rating	Positive News See Recent GEHC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
7/17/2026	Hovde Group 4 of 5 stars		Initiated Coverage	Market Perform	$14.00	-77.87%
7/16/2026	UBS Group 4 of 5 stars	Graham Doyle Not Rated	Lower Target	Neutral	$69.00 ➝ $67.00	+3.27%
7/13/2026	BTIG Research 2 of 5 stars	Ryan Zimmerman 3 of 5 stars	Reiterated Rating	Buy	$75.00	+15.92%
7/8/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Market Perform	$70.00	+8.23%
7/8/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joanne Wuensch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
6/23/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Shagun Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform	$80.00	+31.93%
6/8/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
5/19/2026	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Buy	$95.00 ➝ $80.00	+28.92%
5/15/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Hold (C) ➝ Hold (C-)
5/1/2026	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$95.00 ➝ $88.00	+44.24%
Do this before December or regret it (Ad) Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.
4/30/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$80.00	+34.06%
4/30/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$85.00	+42.65%
4/30/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matt Miksic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$87.00 ➝ $78.00	+31.11%
4/30/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target		$88.00 ➝ $74.00	+22.39%
4/30/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Petrone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target		$90.00 ➝ $80.00	+32.31%
4/30/2026	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$100.00 ➝ $90.00	+47.52%
4/30/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$105.00 ➝ $90.00	+47.52%
4/30/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target		$110.00 ➝ $98.00	+60.63%
4/30/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robbie Marcus Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$80.00 ➝ $65.00	+6.84%
4/30/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$97.00 ➝ $75.00	+24.48%
4/29/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$80.00	+34.24%
2/4/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$80.00 ➝ $85.00	+2.93%
1/5/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Bijou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$82.00 ➝ $92.00	+11.08%
9/29/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:50 PM ET.

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 21, 2026. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

The current stock price is around $63, which is significantly lower than its one-year high, indicating potential for growth.
The company reported a revenue increase of 7.4% year-over-year, showcasing its ability to grow in a competitive market.
GE HealthCare Technologies Inc. has a solid return on equity of 20.46%, reflecting effective management and profitability.
The firm has a low debt-to-equity ratio of 0.95, suggesting a balanced approach to leveraging and financial stability.
With a P/E ratio of approximately 15.62, the stock may be considered undervalued compared to industry peers, presenting a buying opportunity.

GE HealthCare Technologies
Bear Case

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

The company recently missed earnings expectations, reporting $0.99 EPS compared to the consensus estimate of $1.07, which may raise concerns about future performance.
GE HealthCare Technologies Inc. has a relatively low dividend yield of 0.2%, which may not attract income-focused investors.
The stock has shown volatility, with a beta of 0.72, indicating it may not be as stable as some investors prefer.
Despite revenue growth, the net margin of 9.10% suggests that profitability could be a concern if costs rise.
The company's PEG ratio of 1.76 indicates that growth expectations may not justify the current stock price, potentially leading to overvaluation risks.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $76.41, with a high forecast of $98.00 and a low forecast of $14.00.

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last twelve months. There are currently 11 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GEHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GEHC, but not buy additional shares or sell existing shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 24.42% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 2 upgrades and 2 downgrades by analysts.

GE HealthCare Technologies has been rated by research analysts at Argus, Barclays, BMO Capital Markets, BNP Paribas Exane, BTIG Research, Citigroup, Evercore, Hovde Group, HSBC, Jefferies Financial Group, JPMorgan Chase & Co., Mizuho, Oppenheimer, Piper Sandler, Rothschild & Co Redburn, Royal Bank Of Canada, Stifel Nicolaus, The Goldman Sachs Group, UBS Group, Weiss Ratings, and Wells Fargo & Company in the past 90 days.

Analysts like GE HealthCare Technologies more than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.48 while the average consensus rating score for "medical" companies is 2.29. Learn more on how GEHC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

This page (NASDAQ:GEHC) was last updated on 7/22/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

GEHC Analyst Ratings Over Time

GEHC Analyst Recommendations By Month

GEHC Price Targets by Month

GE HealthCare Technologies Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

GE HealthCare Technologies
Bull Case

GE HealthCare Technologies
Bear Case

GEHC Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

GEHC Analyst Ratings Over Time

GEHC Analyst Recommendations By Month

GEHC Price Targets by Month

GE HealthCare Technologies Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

GE HealthCare Technologies Bull Case

GE HealthCare Technologies Bear Case

GEHC Forecast - Frequently Asked Questions

What is GE HealthCare Technologies' forecast for 2026?

Should I buy or sell GE HealthCare Technologies stock right now?

Does GE HealthCare Technologies's stock price have much upside?

Has GE HealthCare Technologies been upgraded or downgraded by Wall Street analysts recently?

What analysts cover GE HealthCare Technologies?

Do Wall Street analysts like GE HealthCare Technologies more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With GE HealthCare Technologies Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

GE HealthCare Technologies
Bull Case

GE HealthCare Technologies
Bear Case